Pharmacokinetics of isoniazid and rifampin in adults with tuberculosis.

被引：0
|
作者：
Auclair, B
Burman, WJ
Stambaugh, JJ
Berning, SE
Ashkin, D
Peloquin, CA
机构：
[1] Natl Jewish, Denver, CO USA
[2] Denver Publ Hlth, Denver, CO USA
[3] AG Holley Hosp, Lantana, FL USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 1999年 / 159卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：A495 / A495
页数：1
相关论文
共 50 条
  • [31] Long-term efficacy of 6-month therapy with isoniazid and rifampin compared with isoniazid, rifampin, and pyrazinamide treatment for pleural tuberculosis
    Francisco Garcia-Rodriguez, Jose
    Valcarce-Pardeiro, N.
    Alvarez-Diaz, H.
    Marino-Callejo, A.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2019, 38 (11) : 2121 - 2126
  • [32] Long-term efficacy of 6-month therapy with isoniazid and rifampin compared with isoniazid, rifampin, and pyrazinamide treatment for pleural tuberculosis
    José Francisco García-Rodríguez
    N. Valcarce-Pardeiro
    H. Álvarez-Díaz
    A. Mariño-Callejo
    European Journal of Clinical Microbiology & Infectious Diseases, 2019, 38 : 2121 - 2126
  • [33] Isoniazid pharmacokinetics in children treated for respiratory tuberculosis
    Schaaf, HS
    Parkin, DP
    Seifart, HI
    Werely, CJ
    Hesseling, PB
    van Helden, PD
    Maritz, JS
    Donald, PR
    ARCHIVES OF DISEASE IN CHILDHOOD, 2005, 90 (06) : 614 - 618
  • [34] Pharmacokinetics of isoniazid in moderately malnourished children with tuberculosis
    Roy, V.
    Gupta, D.
    Gupta, P.
    Sethi, G. R.
    Mishra, T. K.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2010, 14 (03) : 374 - 376
  • [35] The Effect of Rifampin on the Pharmacokinetics of Edoxaban in Healthy Adults
    Mendell, Jeanne
    Chen, Shuquan
    He, Ling
    Desai, Madhuri
    Parasramupria, Dolly A.
    CLINICAL DRUG INVESTIGATION, 2015, 35 (07) : 447 - 453
  • [36] The Effect of Rifampin on the Pharmacokinetics of Edoxaban in Healthy Adults
    Jeanne Mendell
    Shuquan Chen
    Ling He
    Madhuri Desai
    Dolly A. Parasramupria
    Clinical Drug Investigation, 2015, 35 : 447 - 453
  • [37] Hepatotoxicity of rifampin-pyrazinamide and isoniazid preventive therapy and tuberculosis treatment
    van Hest, R
    Baars, H
    Kik, S
    van Gerven, P
    Trompenaars, MC
    Kalisvaart, N
    Keizer, S
    Borgdorff, M
    Mensen, M
    Cobelens, F
    CLINICAL INFECTIOUS DISEASES, 2004, 39 (04) : 488 - 496
  • [38] STABILITY OF ISONIAZID, RIFAMPIN AND PYRAZINAMIDE IN SUSPENSIONS USED FOR THE TREATMENT OF TUBERCULOSIS IN CHILDREN
    SEIFART, HI
    PARKIN, DP
    DONALD, PR
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1991, 10 (11) : 827 - 831
  • [39] Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isoniazid and rifampin
    Park, SK
    Kim, CT
    Song, SD
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 1998, 2 (11) : 877 - 884
  • [40] HEPATOTOXIC REACTIONS IN CHILDREN WITH SEVERE TUBERCULOSIS TREATED WITH ISONIAZID-RIFAMPIN
    TSAGAROPOULOUSTINGA, H
    MATAKIEMMANOUILIDOU, T
    KARIDAKAVALIOTI, S
    MANIOS, S
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1985, 4 (03) : 270 - 273
12345